BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1897842)

  • 21. Tattoos, inks, and cancer.
    Kluger N; Koljonen V
    Lancet Oncol; 2012 Apr; 13(4):e161-8. PubMed ID: 22469126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-Melanoma Skin Cancer Risk Among Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).
    deShazo R; Soltani-Arabshahi R; Krishnasamy S; Langley RG; Kalia S; Ståhle M; Langholff W; Goyal K; Fakharzadeh S; Galindo C; Srivastava B; Krueger G
    J Drugs Dermatol; 2019 Oct; 18(10):1059-1060. PubMed ID: 31603636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
    Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
    Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
    Takashima A; Matsunami E; Yamamoto K; Kitajima S; Mizuno N
    Photodermatol Photoimmunol Photomed; 1990 Oct; 7(5):218-21. PubMed ID: 2091746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ["Superficial spreading melanoma" within a psoriasis focus as a delayed sequela following arsenic therapy for psoriasis].
    Grobe JW
    Berufsdermatosen; 1976; 24(6):167-9. PubMed ID: 1016213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous melanomas in patients treated with psoralens plus ultraviolet A. A case report and the experience of the PUVA Follow-up Study.
    Gupta AK; Stern RS; Swanson NA; Anderson TF
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 1):67-76. PubMed ID: 3403747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study.
    Marcil I; Stern RS
    Lancet; 2001 Sep; 358(9287):1042-5. PubMed ID: 11589933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PUVA photocarcinogenesis in Cheshire.
    Cockayne SE; August PJ
    Clin Exp Dermatol; 1997 Nov; 22(6):300-1. PubMed ID: 9604461
    [No Abstract]   [Full Text] [Related]  

  • 29. Skin carcinomas and treatment with photochemotherapy (PUVA).
    Lindskov R
    Acta Derm Venereol; 1983; 63(3):223-6. PubMed ID: 6192635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Photochemotherapy and skin cancer. The occurrence of premalignant and malignant skin changes in patients with psoriasis treated with photochemotherapy (PUVA therapy)].
    Mørk NJ; Braathen LR; Rajka G; Hoel PS
    Tidsskr Nor Laegeforen; 1988 Mar; 108(8-9):676-8. PubMed ID: 3353970
    [No Abstract]   [Full Text] [Related]  

  • 31. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study.
    Stern RS; Laird N
    Cancer; 1994 Jun; 73(11):2759-64. PubMed ID: 8194017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Research and development of oral psoralen and longwave radiation photochemotherapy: 2000 B.C.-1982 A.D.
    Fitzpatrick TB; Pathak MA
    Natl Cancer Inst Monogr; 1984 Dec; 66():3-11. PubMed ID: 6397691
    [No Abstract]   [Full Text] [Related]  

  • 33. [Puvatherapy and risk of squamous-cell carcinoma].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2012 May; 139(5):414. PubMed ID: 22578351
    [No Abstract]   [Full Text] [Related]  

  • 34. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance.
    van de Kerkhof PC; de Rooij MJ
    Br J Dermatol; 1997 Feb; 136(2):275-8. PubMed ID: 9068750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the safety profile of long-term PUVA therapy.
    Hobbs J; Lebwohl M; Lim HW
    J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):496-7. PubMed ID: 10459130
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
    Forman AB; Roenigk HH; Caro WA; Magid ML
    Arch Dermatol; 1989 Apr; 125(4):515-9. PubMed ID: 2649011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin cancer in Puerto Rico.
    Quintero AL; Torres SM; Sánchez JL
    Bol Asoc Med P R; 1985 Dec; 77(12):502-3. PubMed ID: 3866584
    [No Abstract]   [Full Text] [Related]  

  • 38. Consensus workshop on the toxic effects of long-term PUVA therapy.
    Morison WL; Baughman RD; Day RM; Forbes PD; Hoenigsmann H; Krueger GG; Lebwohl M; Lew R; Naldi L; Parrish JA; Piepkorn M; Stern RS; Weinstein GD; Whitmore SE
    Arch Dermatol; 1998 May; 134(5):595-8. PubMed ID: 9606329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Reasons for the increased incidence of skin cancer].
    Ishihara K
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1380-5. PubMed ID: 17033224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical exposures, medical history, and risk of squamous and basal cell carcinoma of the skin.
    Gallagher RP; Bajdik CD; Fincham S; Hill GB; Keefe AR; Coldman A; McLean DI
    Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):419-24. PubMed ID: 8781736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.